Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma

HPB

Volumn 11, Issue 7, 2009, Pages 570-577

  Quyn, Aaron J ^a   Ziyaie, Dorin ^a   Polignano, Francesco M ^a   Tait, Iain S ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Curative surgery; Hilar cholangiocarcinoma; Photodynamic therapy; Survival

Indexed keywords

CIPROFLOXACIN; CISPLATIN; EPIRUBICIN; FLUOROURACIL; GEMCITABINE; PHOTOFRIN;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEMATEMESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; LIVER METASTASIS; MALE; MORBIDITY; MORTALITY; OVERALL SURVIVAL; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; SEDATION; SEPTICEMIA; SIDE EFFECT; STENT; SURVIVAL TIME;

EID: 73349104409     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00102.x     Document Type: Article

References (56)

1. Altemeier WA, Gall EA, Zinninger MM, Hoxworth PI (1957) Sclerosing carcinoma of the major intrahepatic bile ducts. AMA Arch Surg 75:450-460; discussion 460-461.
2. Klatskin G. (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 38:241-256.
3. Carriaga MT, Henson DE (1995) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 75:171-190.
4. Chamberlain RS, Blumgart LH (2000) Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol 7:55-66.
5. Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ (1997) Cholangiocarcinoma: a review. Gastroenterologist 5:306-315.
6. Pitt HA, Dooley WC, Yeo CJ, Cameron JL (1995) Malignancies of the biliary tree. Curr Probl Surg 32:1-90.
7. Farley DR, Weaver AL, Nagorney DM (1995) 'Natural history' of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 70:425-429.
8. Gerhards MF, den Hartog D, Rauws EA, van Gulik TM, Gonzalez Gonzalez D, Lameris JS et al. (2001) Palliative treatment in patients with unresectable hilar cholangiocarcinoma: results of endoscopic drainage in patients with type III and IV hilar cholangiocarcinoma. Eur J Surg 167:274-280.
9. Guthrie CM, Banting SW, Garden OJ, Carter DC (1994) Segment III cholangiojejunostomy for palliation of malignant hilar obstruction. Br J Surg 81:1639-1641.
10. Lai EC, Chu KM, Lo CY, Fan ST, Lo CM, Wong J (1992) Choice of palliation for malignant hilar biliary obstruction. Am J Surg 163:208-212.
11. Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB (1994) Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 344:1655-1660.
12. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K (1992) Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340:1488-1492.
13. Peters RA, Williams SG, Lombard M, Karani J, Westaby D (1997) The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses. Endoscopy 29:10-16.
14. Prat F, Chapat O, Ducot B, Ponchon T, Pelletier G, Fritsch J et al. (1998) A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 47:1-7.
15. Bruha R, Petrtyl J, Kubecova M, Marecek Z, Dufek V, Urbanek P et al. (2001) Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies - the question of long-term palliation. Hepatogastroenterology 48:631-637.
16. Shinchi H, Takao S, Nishida H, Aikou T (2000) Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J Surg Oncol 75:89-94.
17. Miura Y, Endo I, Togo S, Sekido H, Misuta K, Fujii Y et al. (2001) Adjuvant therapies using biliary stenting for malignant biliary obstruction. J Hepatobiliary Pancreat Surg 8:113-117.
18. Bowling TE, Galbraith SM, Hatfield AR, Solano J, Spittle MF (1996) A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 39:852-855.
19. Pahernik SA, Dellian M, Berr F, Tannapfel A, Wittekind C, Goetz AE (1998) Distribution and pharmacokinetics of Photofrin in human bile duct cancer. J Photochem Photobiol B 47:58-62.
20. Korbelik M, Parkins CS, Shibuya H, Cecic I, Stratford MR, Chaplin DJ (2000) Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy. Br J Cancer 82:1835-1843.
21. Hsi RA, Rosenthal DI, Glatstein E (1999) Photodynamic therapy in the treatment of cancer: current state of the art. Drugs 57:725-734.
22. Luo Y, Kessel D (1997) Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem Photobiol 66:479-483.
23. Levy JG, Obochi M (1996) New applications in photodynamic therapy. Introduction. Photochem Photobiol 64:737-739.
24. McCaughan JS Jr, Mertens BF, Cho C, Barabash RD, Payton HW. (1991) Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. Arch Surg 126:111-113.
25. Ortner MA, Liebetruth J, Schreiber S, Hanft M, Wruck U, Fusco V et al. (1998) Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 114:536-542.
26. Berr F, Wiedmann M, Tannapfel A, Halm U, Kohlhaw KR, Schmidt F et al. (2000) Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 31:291-298.
27. Dumoulin FL, Gerhardt T, Fuchs S, Scheurlen C, Neubrand M, Layer G et al. (2003) Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 57:860-867.
28. Rumalla A, Baron TH, Wang KK, Gores GJ, Stadheim LM, de Groen PC. (2001) Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 53:500-504.
29. Ortner ME, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D et al. (2003) Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125:1355-1363.
30. Bismuth H, Corlette MB (1975) Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140:170-178.
31. Vauthey JN, Blumgart LH (1994) Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 14:109-114.
32. Chang WH, Kortan P, Haber GB (1998) Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 47:354-362.
33. Polydorou AA, Cairns SR, Dowsett JF, Hatfield AR, Salmon PR, Cotton PB et al. (1991) Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 32:685-689.
34. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ et al. (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507-517; discussion 517-519.
35. Deviere J, Baize M, de Toeuf J, Cremer M. (1988) Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc 34:95-101.
36. Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S (2003) Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238:84-92.
37. Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ (2005) Surgical management of hilar cholangiocarcinoma. Ann Surg 241:693-699; discussion 699-702.
38. Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G et al. (1996) Surgical treatment in proximal bile duct cancer. A singlecenter experience. Ann Surg 224:628-638.
39. Liu CL, Lo CM, Lai EC, Fan ST (1998) Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg 133:293-296.
40. Taieb J, Mitry E, Boige V, Artru P, Ezenfis J, Lecomte T et al. (2002) Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma. Ann Oncol 13:1192-1196.
41. Sanz-Altamira PM, Ferrante K, Jenkins RL, Lewis WD, Huberman MS, Stuart KE. (1998) A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer 82:2321-2325.
42. Ellis PA, Norman A, Hill A, O'Brien ME, Nicolson M, Hickish T et al. (1995) Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours. Eur J Cancer 31A:1594-1598.
43. Patt YZ, Hassan MM, Lozano RD, Waugh KA, Hoque AM, Frome AI et al. (2001) Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer. Clin Cancer Res 7:3375-3380.
44. Chen JS, Lin YC, Jan YY, Liau CT (2001) Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas. Anticancer Drugs 12:339-343.
45. Wiedmann M, Berr F, Schiefke I, Witzigmann H, Kohlhaw K, Mossner J et al. (2004) Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest Endosc 60:68-75.
46. Pereira SP, Ayaru L, Rogowska A, Mosse A, Hatfield AR, Bown SG (2007) Photodynamic therapy of malignant biliary strictures using mesotetrahydroxyphenylchlorin. Eur J Gastroenterol Hepatol 19:479-485.
47. Henke AC, Jensen CS, Cohen MB (2002) Cytologic diagnosis of adenocarcinoma in biliary and pancreatic duct brushings. Adv Anat Pathol 9:301-308.
48. Ponchon T, Gagnon P, Berger F, Labadie M, Liaras A, Chavaillon A et al. (1995) Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc 42:565-572.
49. Baron TH, Harewood GC, Rumalla A, Pochron NL, Stadheim LM, Gores GJ et al. (2004) A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol 2:214-219.
50. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM et al. (2004) A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 99:1675-1681.
51. Todoroki T, Kawamoto T, Koike N, Takahashi H, Yoshida S, Kashiwagi H et al. (2000) Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg 87:306-313.
52. Gerhards MF, van Gulik TM, de Wit LT, Obertop H, Gouma DJ. (2000) Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma - a single center experience. Surgery 127:395-404.
53. Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H et al. (2001) Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233:385-392.
54. Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T et al. (2004) Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 240:95-101.
55. Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T et al. (2003) Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 238:73-83.
56. Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K et al. (2006) Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to R/R2 resection. Ann Surg 244:230-239.